LEGN
Legend Biotech

1,035
Mkt Cap
$3.61B
Volume
3,206.00
52W High
$45.30
52W Low
$16.24
PE Ratio
-14.98
LEGN Fundamentals
Price
$20.00
Prev Close
$19.56
Open
$19.82
50D MA
$19.60
Beta
0.50
Avg. Volume
2.41M
EPS (Annual)
-$1.61
P/B
3.57
Rev/Employee
$395,408.65
$3,472.23
Loading...
Loading...
News
all
press releases
Legend Biotech Q4 Earnings Call Highlights
Legend Biotech (NASDAQ:LEGN) executives highlighted accelerating global demand for CARVYKTI, improving profitability metrics, and expanding manufacturing capacity during the company's fourth quarter...
MarketBeat·23h ago
News Placeholder
More News
News Placeholder
Legend Biotech Corporation Sponsored ADR (NASDAQ:LEGN) Given Consensus Rating of "Moderate Buy" by Analysts
Legend Biotech Corporation Sponsored ADR (NASDAQ:LEGN - Get Free Report) has received a consensus recommendation of "Moderate Buy" from the sixteen research firms that are presently covering the...
MarketBeat·1d ago
News Placeholder
Triata Capital Ltd Purchases 54,300 Shares of Legend Biotech Corporation Sponsored ADR $LEGN
Triata Capital Ltd grew its position in shares of Legend Biotech Corporation Sponsored ADR (NASDAQ:LEGN - Free Report) by 50.5% during the third quarter, according to the company in its most recent...
MarketBeat·3d ago
News Placeholder
Legend Biotech (NASDAQ:LEGN) Trading Up 5.5% - Here's Why
Legend Biotech (NASDAQ:LEGN) Shares Up 5.5% - Time to Buy...
MarketBeat·5d ago
News Placeholder
Legend Biotech (LEGN) Projected to Post Earnings on Tuesday
Legend Biotech (NASDAQ:LEGN) will be releasing its Q4 2025 earnings before the market opens on Tuesday, March 10. (View Earnings Report at...
MarketBeat·8d ago
News Placeholder
Westfield Capital Management Co. LP Lowers Stock Position in Legend Biotech Corporation Sponsored ADR $LEGN
Westfield Capital Management Co. LP trimmed its stake in Legend Biotech Corporation Sponsored ADR (NASDAQ:LEGN - Free Report) by 5.8% during the third quarter, according to its most recent 13F filing...
MarketBeat·13d ago
News Placeholder
Legend Biotech (NASDAQ:LEGN) Downgraded to "Hold" Rating by Truist Financial
Truist Financial lowered shares of Legend Biotech from a "strong-buy" rating to a "hold" rating in a research note on Monday...
MarketBeat·15d ago
News Placeholder
Legend Biotech (NASDAQ:LEGN) Shares Gap Up - Still a Buy?
Legend Biotech (NASDAQ:LEGN) Shares Gap Up - Here's Why...
MarketBeat·16d ago
News Placeholder
Legend Biotech Corporation Sponsored ADR (NASDAQ:LEGN) Given Average Rating of "Moderate Buy" by Brokerages
Legend Biotech Corporation Sponsored ADR (NASDAQ:LEGN - Get Free Report) has been given a consensus rating of "Moderate Buy" by the sixteen brokerages that are presently covering the firm, Marketbeat...
MarketBeat·26d ago
News Placeholder
Legend Biotech (NASDAQ:LEGN) Lowered to "Neutral" Rating by Rothschild & Co Redburn
Rothschild & Co Redburn downgraded shares of Legend Biotech from a "buy" rating to a "neutral" rating and set a $24.00 price target on the stock. in a report on Thursday...
MarketBeat·27d ago
<
1
2
...
>

Latest LEGN News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.